Literature DB >> 9348253

The clinical outcome in pregnancies of grand grand multiparous women.

K Juntunen1, P Kirkinen, A Kauppila.   

Abstract

OBJECTIVE: To longitudinally evaluate maternal and neonatal complications with relation to birth order, with specific emphasis on grand grand multiparity (at least 10th para).
METHODS: The maternal and neonatal outcome of 1200 pregnancies/deliveries in 96 grand grand multiparas was longitudinally investigated in 4 stages of the mothers' life: the primiparas, the multiparas (2nd-5th paras), the grand multiparas (6th-9th paras) and the grand grand multiparas stage.
RESULTS: The frequency of hypertension, diabetes, placental complications, operative interventions at delivery, macrosomic infants, chromosomal abbreviations and fetal/neonatal anomalies increased with increasing birth order, being at a maximum in grand grand multiparas. The preterm delivery and perinatal mortality rate did not differ between the 3 groups of multiparas. Perinatal outcome was good in each group.
CONCLUSIONS: Grand grand multiparity carries the risk of hypertensive and diabetic complications, which, in turn, often lead to induced or operative deliveries and placental complications. However, grand grand multiparity is not a major problem in societies with a good maternal health care system.

Entities:  

Mesh:

Year:  1997        PMID: 9348253     DOI: 10.3109/00016349709024342

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  Perception of pregnancy related health issues among Arab women living in the United States.

Authors:  Ping Ma; Maria C Magnus; Jeanette H Magnus
Journal:  J Immigr Minor Health       Date:  2013-04

2.  Trends in the occurrence of antenatal and perinatal complications with increasing parity.

Authors:  Pooja R Vaswani; Sangeeta Sabharwal
Journal:  J Obstet Gynaecol India       Date:  2013-03-20

3.  Does parity affect mortality among parous women?

Authors:  H Koski-Rahikkala; A Pouta; K Pietiläinen; A-L Hartikainen
Journal:  J Epidemiol Community Health       Date:  2006-11       Impact factor: 3.710

4.  Population-based study of risk factors for severe maternal morbidity.

Authors:  Kristen E Gray; Erin R Wallace; Kailey R Nelson; Susan D Reed; Melissa A Schiff
Journal:  Paediatr Perinat Epidemiol       Date:  2012-11       Impact factor: 3.980

5.  Parity and risk of death from gallbladder cancer among a cohort of premenopausal parous women in Taiwan.

Authors:  Te-Fu Chan; Chen-Hsuan Wu; Hui-Fen Chiu; Chun-Yuh Yang
Journal:  Int J Environ Res Public Health       Date:  2015-02-05       Impact factor: 3.390

6.  Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study.

Authors:  Melissa A Merritt; Elio Riboli; Neil Murphy; Mai Kadi; Anne Tjønneland; Anja Olsen; Kim Overvad; Laure Dossus; Laureen Dartois; Françoise Clavel-Chapelon; Renée T Fortner; Verena A Katzke; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Carlotta Sacerdote; Salvatore Panico; H Bas Bueno-de-Mesquita; Petra H Peeters; Eiliv Lund; Aurelie Nakamura; Elisabete Weiderpass; J Ramón Quirós; Antonio Agudo; Esther Molina-Montes; Nerea Larrañaga; Miren Dorronsoro; Lluís Cirera; Aurelio Barricarte; Åsa Olsson; Salma Butt; Annika Idahl; Eva Lundin; Nicholas J Wareham; Timothy J Key; Paul Brennan; Pietro Ferrari; Petra A Wark; Teresa Norat; Amanda J Cross; Marc J Gunter
Journal:  BMC Med       Date:  2015-10-30       Impact factor: 8.775

7.  A meta-analysis of selected maternal and fetal factors for perinatal mortality.

Authors:  Yifru Berhan; Asres Berhan
Journal:  Ethiop J Health Sci       Date:  2014-09

8.  Parity and Risk of Stroke among Chinese Women: Cross-sectional Evidence from the Dongfeng-Tongji Cohort Study.

Authors:  Yanmei Zhang; Lijun Shen; Jing Wu; Guiqiang Xu; Lulu Song; Siyi Yang; Yaohua Tian; Jing Yuan; Yuan Liang; Youjie Wang
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.